UP!
| 2016-07-11 | Downgrade | Leerink Swann | Outperform to Market Perform | |
| 2016-06-29 | Downgrade | BTIG Research | Buy to Neutral | |
| 2016-06-29 | Downgrade | Wells Fargo | Outperform to Market Perform | |
| 2016-06-29 | Downgrade | Barclays | Overweight to Equal Weight | $35.00 to $58.00 |
| 2016-06-29 | Downgrade | Wells Fargo & Co. | Outperform to Market Perform | |
| 2016-06-29 | Downgrade | Barclays PLC | Overweight to Equal Weight | $35.00 to $58.00 |
| 2016-06-28 | Downgrade | SunTrust | Buy to Neutral | $60.00 to $58.00 |
| 2016-06-28 | Downgrade | SunTrust Banks Inc. | Buy to Neutral | $60.00 to $58.00 |
| 2016-06-27 | Reiterated Rating | Canaccord Genuity | Buy | $45.00 to $66.00 |
| 2016-06-08 | Initiated Coverage | Guggenheim | Neutral | |
| 2016-05-10 | Reiterated Rating | BTIG Research | Buy | $50.00 to $45.00 |
| 2016-05-05 | Lower Price Target | Barclays | Overweight | $42.00 to $35.00 |
| 2016-05-05 | Lower Price Target | Leerink Swann | Outperform | $45.00 to $40.00 |
| 2016-04-30 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-04-25 | Reiterated Rating | Bank of America | Buy | |
| 2016-04-25 | Reiterated Rating | Bank of America Corp. | Buy | |
| 2016-03-28 | Lower Price Target | Raymond James | Outperform | $43.00 to $42.00 |
| 2016-03-28 | Lower Price Target | Raymond James Financial Inc. | Outperform | $43.00 to $42.00 |
| 2016-03-24 | Upgrade | Bank of America | Neutral to Buy | |
| 2016-03-02 | Lower Price Target | BTIG Research | Buy | $70.00 to $50.00 |
| 2016-02-27 | Reiterated Rating | Northland Securities | Hold | |
| 2016-02-26 | Lower Price Target | Leerink Swann | Outperform | $60.00 to $45.00 |
| 2016-02-26 | Lower Price Target | Northland Securities | Market Perform | $45.00 to $35.00 |
| 2016-01-31 | Reiterated Rating | William Blair | Market Perform | |
| 2016-01-28 | Upgrade | Wells Fargo | Market Perform to Outperform | |
| 2016-01-28 | Upgrade | Raymond James | Market Perform to Outperform | |
| 2016-01-28 | Reiterated Rating | Canaccord Genuity | Buy | $70.00 |
| 2016-01-28 | Reiterated Rating | BTIG Research | Buy | $70.00 |
| 2016-01-14 | Reiterated Rating | BTIG Research | Buy | $70.00 |
| 2016-01-13 | Reiterated Rating | Leerink Swann | Outperform | $60.00 |
| 2016-01-13 | Reiterated Rating | Oppenheimer | Market Perform | |
| 2016-01-13 | Reiterated Rating | Oppenheimer Holdings Inc. | Market Perform | |
| 2016-01-12 | Reiterated Rating | Canaccord Genuity | Buy | $70.00 |
| 2016-01-12 | Reiterated Rating | Sterne Agee CRT | Buy | $60.00 to $55.00 |
| 2016-01-12 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $56.00 to $39.00 |
| 2016-01-07 | Reiterated Rating | BTIG Research | Buy | $70.00 |
| 2016-01-04 | Reiterated Rating | Northland Securities | Hold | $45.00 |
| 2015-12-08 | Initiated Coverage | SunTrust | Buy | $80.00 |
| 2015-11-13 | Boost Price Target | Goldman Sachs | $41.00 to $45.00 | |
| 2015-11-13 | Boost Price Target | Goldman Sachs Group Inc. | $41.00 to $45.00 | |
| 2015-11-08 | Reiterated Rating | Canaccord Genuity | Buy | $70.00 |
| 2015-11-05 | Reiterated Rating | BTIG Research | Buy | $70.00 |
| 2015-10-30 | Downgrade | Piper Jaffray | Overweight to Neutral | $48.00 to $44.00 |
| 2015-10-30 | Lower Price Target | Leerink Swann | $63.00 to $60.00 | |
| 2015-10-30 | Downgrade | Piper Jaffray Cos. | Overweight to Neutral | $48.00 to $44.00 |
| 2015-10-28 | Boost Price Target | Credit Suisse | $34.00 to $48.00 | |
| 2015-10-28 | Reiterated Rating | Canaccord Genuity | Buy | $70.00 |
| 2015-10-28 | Boost Price Target | Credit Suisse Group AG | $34.00 to $48.00 | |
| 2015-10-26 | Upgrade | BTIG Research | Neutral to Buy | $80.00 |
| 2015-10-14 | Lower Price Target | Sterne Agee CRT | $93.00 to $60.00 | |
| 2015-10-14 | Upgrade | Goldman Sachs | Sell to Neutral | $67.00 to $42.00 |
| 2015-10-14 | Reiterated Rating | Canaccord Genuity | Buy | $106.00 |
| 2015-10-13 | Reiterated Rating | Piper Jaffray | Buy | $86.00 to $48.00 |
| 2015-10-13 | Reiterated Rating | Leerink Swann | Buy | $85.00 to $63.00 |
| 2015-10-13 | Downgrade | Oppenheimer | Outperform to Market Perform | |
| 2015-10-13 | Lower Price Target | Northland Securities | Market Perform | $60.00 to $45.00 |
| 2015-10-02 | Upgrade | Capital Ideas Research | Underperform to Marketperform | |
| 2015-10-01 | Upgrade | Northland Securities | Under Perform to Market Perform | $60.00 |
| 2015-09-28 | Reiterated Rating | Leerink Swann | Outperform | $85.00 |
| 2015-09-25 | Reiterated Rating | Canaccord Genuity | Buy | $106.00 |
| 2015-09-15 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2015-09-09 | Reiterated Rating | Canaccord Genuity | Buy | $106.00 |
| 2015-09-08 | Reiterated Rating | Leerink Swann | Outperform | $110.00 to $85.00 |
| 2015-09-06 | Reiterated Rating | William Blair | Market Perform | |
| 2015-09-02 | Reiterated Rating | Northland Securities | Sell | $60.00 |
| 2015-09-02 | Reiterated Rating | Canaccord Genuity | Buy | $106.00 |
| 2015-09-02 | Reiterated Rating | Oppenheimer | Buy | $100.00 |
| 2015-09-02 | Downgrade | Raymond James | Outperform to Market Perform | |
| 2015-09-02 | Downgrade | BTIG Research | Buy to Neutral | |
| 2015-09-02 | Lower Price Target | Sterne Agee CRT | Buy | $103.00 to $93.00 |
| 2015-08-27 | Lower Price Target | Goldman Sachs | $81.00 to $78.00 | |
| 2015-08-10 | Reiterated Rating | Credit Suisse | Buy | |
| 2015-08-09 | Reiterated Rating | BTIG Research | Buy | $105.00 |
| 2015-08-03 | Reiterated Rating | Piper Jaffray | Buy | $100.00 to $108.00 |
| 2015-08-03 | Boost Price Target | Leerink Swann | Outperform | $90.00 to $110.00 |
| 2015-07-31 | Boost Price Target | Barclays | Overweight | $100.00 to $105.00 |
| 2015-07-31 | Boost Price Target | Oppenheimer | Outperform | $94.00 to $100.00 |
| 2015-07-30 | Reiterated Rating | Canaccord Genuity | Buy | $106.00 |
| 2015-07-30 | Reiterated Rating | BTIG Research | Buy | $90.00 |
| 2015-07-28 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $85.00 to $104.00 |
| 2015-07-23 | Reiterated Rating | Northland Securities | Sell | |
| 2015-07-20 | Reiterated Rating | BTIG Research | Buy | $90.00 |
| 2015-07-15 | Lower Price Target | Northland Securities | Under Perform | $70.00 to $60.00 |
| 2015-05-09 | Reiterated Rating | Sterne Agee CRT | Buy | $109.00 to $103.00 |
| 2015-05-08 | Reiterated Rating | Canaccord Genuity | Buy | $50.00 |
| 2015-05-08 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $101.00 to $85.00 |
| 2015-05-01 | Lower Price Target | Barclays | Overweight | $105.00 to $100.00 |
| 2015-04-20 | Lower Price Target | Oppenheimer | Outperform | $98.00 to $94.00 |
| 2015-04-16 | Lower Price Target | Canaccord Genuity | Buy | $110.00 to $106.00 |
| 2015-04-01 | Reiterated Rating | Canaccord Genuity | Buy | $110.00 |
| 2015-02-27 | Set Price Target | Canaccord Genuity | Buy | $115.00 to $110.00 |
| 2015-02-27 | Boost Price Target | Leerink Swann | Outperform | $90.00 to $105.00 |
| 2015-02-23 | Set Price Target | Canaccord Genuity | Buy | $115.00 to $110.00 |
| 2015-02-02 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $93.00 to $103.00 |
| 2014-11-06 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $100.00 to $93.00 |
| 2014-10-31 | Reiterated Rating | Oppenheimer | Outperform | $112.00 to $98.00 |
| 2014-10-31 | Reiterated Rating | Canaccord Genuity | Buy | $125.00 to $115.00 |
| 2014-10-14 | Upgrade | Piper Jaffray | Neutral to Overweight | $91.00 |
| 2014-08-01 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $128.00 to $125.00 |
| 2014-08-01 | Lower Price Target | Leerink Swann | $120.00 to $105.00 | |
| 2014-05-02 | Reiterated | WallachBeth | Buy | $110 to $125 |
| 2014-05-02 | Boost Price Target | WallachBeth Capital | Buy | $110.00 to $125.00 |
| 2014-05-02 | Boost Price Target | Oppenheimer | Outperform | $103.00 to $112.00 |
| 2014-05-02 | Boost Price Target | Canaccord Genuity | $121.00 to $125.00 | |
| 2014-04-14 | Upgrade | Oppenheimer | Market Perform to Outperform | |
| 2014-04-14 | Upgrade | BTIG Research | Neutral to Buy | $100.00 |
| 2014-04-14 | Downgrade | Goldman Sachs | Neutral to Sell | $94.00 to $73.00 |
| 2014-02-27 | Boost Price Target | Canaccord Genuity | $115.00 to $121.00 | |
| 2014-02-20 | Initiated Coverage | BTIG Research | Neutral | |
| 2014-01-09 | Reiterated Rating | Barclays | Overweight | $100.00 to $110.00 |
| 2013-12-16 | Boost Price Target | JPMorgan Chase & Co. | $125.00 to $131.00 | |
| 2013-12-03 | Boost Price Target | Canaccord Genuity | $110.00 to $115.00 | |
| 2013-11-26 | Initiated Coverage | CRT Capital | Buy | $109.00 |
| 2013-10-07 | Reiterated Rating | Canaccord Genuity | Buy | $110.00 |
| 2013-10-07 | Lower Price Target | Oppenheimer | Market Perform | $95.00 to $89.00 |
| 2013-04-30 | Reiterated | Northland Capital | Under Perform | $60 to $70 |
| 2013-03-12 | Reiterated | UBS | Neutral | $95 to $87 |
| 2012-11-27 | Reiterated | UBS | Neutral | $95 to $88 |
| 2012-11-12 | Reiterated | UBS | Buy | $110 to $100 |
| 2012-04-23 | Upgrade | Barclays | Equal Weight to Overweight | $80 to $80 |
| 2012-01-17 | Downgrade | Morgan Keegan | Outperform to Mkt Perform | |
| 2011-05-03 | Initiated | Wunderlich | Hold | $80 |
| 2011-04-11 | Downgrade | Auriga U.S.A | Buy to Hold | $101 to $80 |
| 2016-07-11 | Downgrade | Leerink Swann | Outperform to Market Perform | |
| 2016-06-29 | Downgrade | BTIG Research | Buy to Neutral | |
| 2016-06-29 | Downgrade | Wells Fargo | Outperform to Market Perform | |
| 2016-06-29 | Downgrade | Barclays | Overweight to Equal Weight | $35.00 to $58.00 |
| 2016-06-29 | Downgrade | Wells Fargo & Co. | Outperform to Market Perform |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In HTWR 1 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| SHAPIRO ROBERT N | 1000 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| ADAGE CAPITAL PARTNERS GP LLC | 10.13% (1722969) | ADXS / AMAG / BDBD / CALA / FPRX / HTWR / IGOI / PBYI / PSUN / PTGX / |
| Harrison Seth Loring | 0.78% (133393) | HTWR / TKAI / |
| Godshall Douglas Evan President & Chief Exec Officer | 0.50% (84345) | HTWR / PSDV / VTL / |
| MCAREE PETER F SVP, CFO and Treasurer | 0.11% (19005) | HTWR / |
| Stockman Robert Bernard | 0.10% (17814) | HTWR / |
| Knopf Lawrence J General Counsel | 0.10% (17608) | HTWR / |
| LaRose Jeffrey Chief Scientific Officer | 0.07% (12482) | HTWR / |
| Schuermann James SVP, Sales & Marketing | 0.07% (12043) | HTWR / |
| BARBERICH TIMOTHY J | 0.07% (11107) | DARA / HTWR / TKAI / VSTM / |
| Yocher Robert E SVP, Regulatory & Quality | 0.06% (9839) | HTWR / |
| LARKIN C RAYMOND JR | 0.05% (8000) | ALGN / HTWR / |
| Wade Denis Newell | 0.03% (5750) | HTWR / |
| FELDMANN CYNTHIA L | 0.03% (4750) | HGR / HTWR / STE / UFPT / |
| Thomas Robert Bain | 0.03% (4510) | HTWR / |
| Strong Mark Senior VP, R&D and Quality | 0.02% (3513) | HTWR / |
| OESTERLE STEPHEN N | 0.01% (1000) | BAX / HTWR / |
UM